期刊文献+

糖尿病肾病患者血脂异常与尿蛋白关系 被引量:38

Relationship Between Dyslipidemia and Proteinuria in Patients with Diabetic Nephropathy
下载PDF
导出
摘要 探讨糖尿病肾病(DN)患者血脂异常与尿蛋白关系.选取122例住院的DN患者,年龄(62.26±12.67)岁,女性49例,男性73例,测定血脂代谢各指标,同时留取24h尿蛋白定量(24h pro),依据蛋白尿定量分为肾病和非肾病综合征组,比较两组相关血脂指标,并行相关性分析比较.肾病综合征组患者的TC(总胆固醇)、NHDL、Lpa和Apo-B水平均显著高于非肾病综合征组(P<0.05);TC、NHDL、Apo-B和Apo-E均分别与24h尿蛋白定量和糖化血红蛋白(HbA1C)相关(P<0.01),Lpa与24h尿蛋白定量及肾小球滤过率(eGFR)相关,LDL-C及TG仅与HbA1C相关(P<0.01),Apo-A1仅与24hpro相关(P<0.05);各血脂指标依据四分位法分组,TC、NHDL-C、TG、Apo-A1、Apo-B、Lpa及Apo-E随着数值升高,组内24h尿蛋白定量(≥3.5g)百分比例增高(P<0.05),而LDL-C及HDL-C组内比较无统计学差异(P>0.05).DN患者随着24h蛋白尿增多,血脂异常更为显著,尤其在肾病综合征患者以TC、NHDL、Lpa及Apo-B升高为主,而血脂异常进一步加重肾脏病进展,有效控制血脂有望改善肾脏病预后. The relationship between 24 h urine protein excretion with dyslipidemia in diabetic nephropathy (DN) patients was evaluated. A total of 122 DN patients (49 females and 73 males) with an average age of (62.26±12.67) were included in this study. 24-hour urine were collected for 24 hprotein(24hpro) meas urement and blood samples were taken as lipid parammeters. According to 24 h pro assays, subjects were divided into nephrotic group and non-nephrotic group. Lipid profiles and correlation analysis were corn pared between the two groups. It is found that the levels of total cholesterol(TC), non high density lipo- protein (NHDL), lipoprotein (a) [Lp(a)], and apolipoprotein B (ApoB) were much higher in nephrotic- group compared with non-nephrotic one (P〈0.05). In correlation analysis, TC, NHDL, Apo-B and Apo- E were found to be related to 24 h urine protein and HbA1C (P〈0.01) respectively and Lpa was related to 24 h pro and eGFR. LDL-C and TG were independently associated with HbA1C (P〈0.01) while Apo-A1 was only associated with 24 h pro (P〈0.05). In each group classified according to quartiles of lipid pro- file, it is found that the proportion of patients with 〉3.5 g/24 h urine protein excretion grew progressive- ly with the increase in TC, NHDL-C, TG, Apo-A1, Apo-B,Lpa and Apo-E (P^0.05) while LDL-C and HDL-C had no statistical differences (P^0.05). Conclusion. In patients with diabetic nephropathy, an obvious dyslipidemia was observed with increase of 24 h urine protein excretion, especially in those with nephrotic syndrome who mainly present with the an elevation in TC, NHDL, Lpa and Apo-B. Since dys- lipidemia could aggravate the progress of kidney disease, an effective control of lipid profile is likely to im- prove the prognosis.
出处 《上海交通大学学报》 EI CAS CSCD 北大核心 2016年第3期478-482,共5页 Journal of Shanghai Jiaotong University
基金 国家自然科学基金项目(81270824)
关键词 糖尿病肾病 血脂异常 非高密度脂蛋白胆固醇 脂蛋白A 尿蛋白 diabetic nephropathy dyslipidemia non-high density lipoprotein lipoprotein (a) urine protein
  • 相关文献

参考文献16

  • 1CHEN S C, TSENG C H. Dyslipidemia, kidney disease, and cardiovascular disease in diabetic patients[J]. Rev Diabet Stud, 2013, 10(2-3):88-100.
  • 2TSENG C H. Differential dyslipidemia associated with albuminuria in type 2 diabetic patients in Taiwan[J]. Clin Biochem, 2009, 42(10-11):1019-1024.
  • 3LING Y, LI X, GU Q, et al. Circulating ApoE level is independently associated with urinary albumin excretion in type 2 diabetic patients[J]. Intern Med, 2011, 50(24):2961-2966.
  • 4PAN J, GAO F, BAO Y, et al. Non-high-density lipoprotein cholesterol is associated more closely with albuminuria in Chinese type 2 diabetic patients with normal renal function, compared with traditional lipid parameters[J]. J Clin Lipidol, 2012, 6(4):382-387.
  • 5LEVEY A S, BOSCH J P, LEWIS J B, et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in Renal Disease Study Group[J]. Ann Intern Med, 1999, 130: 461-470.
  • 6TSIMIHODIMOS V, DOUNOUSI E, SIAMOPOULOS K C.Dyslipidemia in chronic kidney disease: an approach to pathogenesis and treatment[J]. Am J Nephrol, 2008, 28(6):958-973.
  • 7LU W, RESNICK H E, JABLONSKI K A, et al. Non-HDL cholesterol as a predictor of cardiovascular disease in type 2 diabetes: The strong heart study[J]. Diabetes Care, 2003, 26(1):16-23.
  • 8MIREMADI S, SNIDERMAN A, FROHLICH J. Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders[J]. Clin Chem, 2002, 48:484-488.
  • 9TSENG C H. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan[J]. Diabetes Care, 2004, 27:517-521.
  • 10GALLE J, SCHNEIDER R, HEINLOTH A, et al. Lp(a) and LDL induce apoptosis in human endothelial cells and in rabbit aorta: role of oxidative stress[J]. Kidney Int, 1999, 55:1450-1461.

同被引文献461

引证文献38

二级引证文献258

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部